The DH programme board responsible for "rebalancing" medicines legislation and pharmacy regulation "will consult...a range of pharmacy stakeholders, including patients and the public" before submitting changes to pharmacy supervision legislation, it confirmed to C+D yesterday (September 19).
Free to registered users
Register to gain full access to C+D and C+D Community content
Already registered?